Introduction
authentication of the plant samples were performed by Biologist Laura Doval Ugalde at Escuela Nacional de Ciencias Biológicas of Instituto Politécnico Nacional (ENCB-IPN). The plant samples were compared with a voucher specimen deposited in the ENCB herbarium under number 247.
Ethnobotanical survey
A survey was conducted around the municipality of San Pedro Tlaquilpan, Zempoala, State of Hidalgo using a questionnaire to interview individuals with knowledge on the subject matter as herb seller, traditional medical healers and consumers about the part of the plant and the usefulness of E. polystachya in ethnomedicine (Bahmani et al., 2014) . A specimen of the plant was shown to people at the time of the interview to avoid confusion.
Preparation of the aqueous extract
The bark was air-dried at room temperature in the shade, and then was ground in a mill (FITZ ® MILL model D Comminutor, Industrial Drive Elmhorst, USA). The E. polystachya bark aqueous extract was freshly prepared just before administration by decoction as follows. A part of the bark of E. polystachya was boiled at 100°C in water for 5 min and subsequently filtered. All doses of extract used were calculated respect to the weight of starting dry material.
Phytochemical screening
The secondary metabolites of aqueous extract were detected by standard color and precipitation phytochemical tests. Briefly, Dragendorff, Mayer, Sonnenschain and Wagner reactions were used to identify alkaloids. Fehling and Benedict reactions for reductor sugars. Erlich reaction and observation under UV light of alkalinized extracts for coumarins. Kedde, Legal and Baljet reactions for cardiac glycosides. A frothing test was done for saponins. The tannins were identified by FeCl3 test and jelly reagent. Liebermann-Buchard reaction for triterpenoids and steroids. Bornträger reaction for quinones and Shinoda reaction for flavonoids were used, among others (Meléndez-Camargo et al., 2014; Saleem et al., 2015) .
Experimental animals
Adult female Wistar rats (180-220 g) and female NIH mice (20-30 g) were used. They were housed and maintained in the animal house at room temperature (22-24°C) and 50-55% relative humidity, with day/ night cycles of 12 × 12 hours. The animals were fed a standard rodent diet with water ad libitum. Care and handling of animals followed internationally accepted procedures according to the Institute for Laboratory Animal Research´s Guide for Care and Use of Laboratory Animals.
Reagents and drug
Reagent-grade reagents were used. Furosemide (Lasix ® ) was used as reference diuretic drug.
Diuretic activity of aqueous extract of E. polystachya

Effect of aqueous extract on urinary flow rate
The experiments were carried out in un-anesthetized rats. The rats were formed into six random treatment groups. Control group received water (1 mL/kg body weight (bw)), furosemide-treated group (4 mg/kg) and four groups treated with the extract at the doses of 125, 250, 500 and 750 mg/kg, respectively. The doses of extract used were calculated respect to the weight of starting dry material. In all groups, the administration was per os and there were at least six animals per group.
At the beginning of the experiment, the urinary bladder was emptied by gentle compression of the abdomen, as previously described (Meléndez et al., 2004) , subsequently, the treatments were administered. The animals were kept during 6 hours in individual metabolic cages in a quiet and warm environment under fluid and food deprivation. At the end of this period, the sample of urine was obtained; also by abdominal compression to ensure complete emptiness of the bladder; urine volume was measured. The animals were decapitated and blood samples were obtained.
Effects on electrolyte balance
Sodium and potassium concentrations were measured in the urine and plasma samples (Flame photometer Corning 400, Corning Medical and Scientific, England) from all rats. Subsequently, urinary excretions and clearances of sodium and potassium were calculated (Meléndez et al., 2004) .
Effect on glomerular filtration rate Glomerular filtration rate was estimated by the clearance of endogenous creatinine. Plasma and urinary creatinine were determined by the method of Jaffe alkaline picrate modified by Meléndez et al., 2004. Creatinine clearance and fractional excretion of sodium and potassium were calculated using the conventional equations (1 and 2):
Where, Cx and Ccreat are the clearance (mL/min) of substance x and creatinine, respectively. Ux and Px are the concentrations (µEq/L) of substance x in urine and plasma, respectively, and V is the urinary flow (mL/min). FEx is the fractional excretion (%) of the substance x Acute toxicity study An acute toxicity study was performed in mice. Mice were fasted overnight with water given ad libitum and randomly assigned into five treatment groups. Four animals were used for complete evaluation at each dose level. The aqueous extract at doses from 2, 4, 8 and 16 g/kg were administered per os. Water was administered to the control group. All deviations in general behavior associated with the administration of E. polystachya were monitored and recorded continuously for the first 3 hours after the administration. For the next 14 days, the number of dead animals was also recorded. During this period, the animals had access to food and water ad libitum (Hilaly et al., 2004; Mukinda and Eagles, 2010) .
Statistical analysis
All data are expressed as means ± SEM (standard error of the mean). To perform statistical analyses, Sigma Plot® 11.0 software was used. Statistical analyses were performed with one-way analysis of variance (ANOVA). The statistical test Student-Newman-Keuls (S-N-K) was used for post-hoc comparisons. Significant differences were set at p values less than 0.05.
Results
One hundred questionnaires were applied which showed that it was generally called 'palo dulce' (sweet wood), 'palo azul' (blue wood) and 'hierba de la víbora'. E. polystachya is specially used to treat several diseases as kidney pain (42%), urolithiasis (31%), diuretic (15%), anuria or oliguria (7%) and renal infection (5%). On the other hand, its use during inflammatory processes also was mentioned.
E. polystachya is prepared as an infusion, decoction or maceration, using one or two small pieces of the bark in one liter of water. Many of interviewed people indicated that the main way of use of plant was by the decoction of the bark for enhancing the urinary volume, and it was taken orally as tea until the symptoms disappear.
Phytochemical screening of the extract revealed the presence of medicinal active constituents as anthraquinones, cardiac glycosides, coumarins, reductor sugars, saponins and tannins. Flavonoids were the major constituents. However, the extract was devoid of alkaloids, cyanogenic glycosides and sesquiterpenlactones.
Rats treated with extract (500 and 750 mg/kg) exhibited an increase (p<0.05) in urinary flow rate, similar to that of furosemide (Figure 1 ).
The increment of the urinary excretion of sodium was depended on the doses of the extract, but only the increments in 750 mg/kg of extract and furosemide were different respect to the control group (Figure 2 ). E. polystachya did not increase the urinary excretion of potassium, in contrast to furosemide (Table I ).
The basal values of plasma electrolytes were similar in all groups (data not shown). Sodium clearance increased (p<0.05) in the extract (500 and 750 mg/kg) and furosemide groups respect to control group. The increments were dose-dependent. However, the extract did not increase the potassium clearance, in contrast to furosemide (Table I) . The glomerular filtration rate remained unchanged in all treated groups. Increments in fractional excretion of sodium and potassium were shown in the furosemide group, but not in the groups treated with the extract (Table II) . None of the doses of aqueous extract produced mortality. Moreover, any signs of toxicity were observed after oral administration. Because no deaths were observed at the dose levels used, the LD50 was assumed greater than 16 g/kg.
Discussion
The present results reveal that E. polystachya aqueous extract (500 and 750 mg/kg) induced an important diuretic action because increments in the urinary flow and urinary excretion of sodium similar to furosemide were shown. This effect on urinary sodium excretion is in proportion to the ability of the plant to excrete water, which suggests that the diuretic effect of E. polystachya is saluretic type in contrast to aquaretic type typical of most phytodiuretic agents (Mekonnen et al., 2010) .
Only extract at a dose of 750 mg/kg induced an increment in sodium clearance similar to furosemidetreated group. However, in contrast to furosemide, the extract does not affect the potassium clearance, the fractional excretion of sodium and potassium. This suggesting that the extract is acting as potassiumsparing diuretic and this effect should be viewed as a Table I Effect of E. polystachya aqueous extract on urinary excretion and clearances of sodium and potassium favourable feature of the extract in regards to electrolyte excretion (Gasparotto et al., 2011) , for example the extract exhibited advantageous effect with regard to hypokalemia, a potential adverse effect of furosemide (Mekonnen et al., 2010; Sadki et al., 2010) . The glomerular filtration rate was not modified in all treated groups; but this variable is modified in conventional treatment with high doses of furosemide as a side effect (Meléndez et al., 2004) . Since E. polystachya can excrete sodium and water is possible to suggest that the extract exerted its diuretic effect by inhibiting tubular reabsorption of water and electrolytes.
The diuretic capability of plants has been described in previous studies with other medicinal plants (Benjumea et al., 2005; Lahlou et al., 2007; Martín-Herrera et al., 2007; Adam et al., 2009; Amuthan et al., 2012) . However, the mechanism of action of these has not been elucidated because of aqueous or organic extracts with biological activity, are a mixture of compounds may be working by synergism and some hypotheses have been formulated in order to explain medical properties of plants.
Several authors have reported a relationship between the presence of polar secondary metabolites in plants and its diuretic activity. For example, the presence of polar organic compounds as flavonoid glycosides and saponosids in plants can produce diuresis because they are more likely to have contact with renal tissues (Lahlou et al., 2007; Adam et al., 2009; Amuthan et al., 2012; Meléndez-Camargo et al., 2014) . Natural compounds in medicinal plants might stimulate the regional blood flow and/or promote an initial vasodilatation as do the osmotic diuretics and xanthenes (Osswald and Schnermann, 2011; Saleem et al., 2015) , but might also produce inhibition of renal tubular reabsorption of water and anions (Abdala et al., 2012; Gasparotto et al., 2011) ; the result in these cases is diuresis. In addition, the electrolytes present in plants can induce a diuretic activity (Adam et al., 2009 ).
So, one can suppose that the phenolic compounds such as anthraquinones, coumarins, saponins, tannins and flavonoids detected in the extract might be responsible, at least in part, for the observed diuretic effect and that they may act individually or synergistically.
Despite the widespread use of herbal medicines, few scientific studies have been undertaken to ascertain the safety and efficacy of traditional remedies (Hilaly et al., 2004; Mukinda and Eagles, 2010) . The present investigation shows that the E. polystachya does not produce death, hence it can be concluded that E. polystachya is not toxic orally.
Conclusion
The bark of E. polystachya induces an increase in urinary excretion of water and sodium, similar to furosemide, but with the advantage of a potassium-saving effect. These findings support the claims of the diuretic efficacy of the bark of E. polystachya in the Mexican Traditional Medicine. 
